Literature DB >> 15504952

Molecular mechanisms of insulin resistance that impact cardiovascular biology.

Cecilia C Low Wang1, Marc L Goalstone, Boris Draznin.   

Abstract

Insulin resistance is concomitant with type 2 diabetes, obesity, hypertension, and other features of the metabolic syndrome. Because insulin resistance is associated with cardiovascular disease, both scientists and physicians have taken great interest in this disorder. Insulin resistance is associated with compensatory hyperinsulinemia, but individual contributions of either of these two conditions remain incompletely understood and a subject of intense investigation. One possibility is that in an attempt to overcome the inhibition within the metabolic insulin-signaling pathway, hyperinsulinemia may continue to stimulate the mitogenic insulin-signaling pathway, thus exerting its detrimental influence. Here we discuss some of the effects of insulin resistance and mechanisms of potentially detrimental influence of hyperinsulinemia in the presence of metabolic insulin resistance.

Entities:  

Mesh:

Year:  2004        PMID: 15504952     DOI: 10.2337/diabetes.53.11.2735

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  64 in total

1.  Insulin resistance and incident peripheral artery disease in the Cardiovascular Health Study.

Authors:  Kathryn A Britton; Kenneth J Mukamal; Joachim H Ix; David S Siscovick; Anne B Newman; Ian H de Boer; Evan L Thacker; Mary L Biggs; J Michael Gaziano; Luc Djoussé
Journal:  Vasc Med       Date:  2012-03-08       Impact factor: 3.239

Review 2.  C-Peptide in insulin resistance and vascular complications: teaching an old dog new tricks.

Authors:  Dennis Bruemmer
Journal:  Circ Res       Date:  2006-11-24       Impact factor: 17.367

Review 3.  Effects of chronic hyperinsulinemia in insulin-resistant patients.

Authors:  Sergio Muntoni; Sandro Muntoni; Boris Draznin
Journal:  Curr Diab Rep       Date:  2008-06       Impact factor: 4.810

4.  Comparison of EQ-5D-3L and metabolic components between patients with hyperhidrosis and the general population: a propensity score matching analysis.

Authors:  Yea-Chan Lee; Young Kyung You; Jun Hyuk Lee; Duk Hwan Moon; Sungsoo Lee; Soyoung Jeon; Hye Sun Lee; Ji-Won Lee
Journal:  Qual Life Res       Date:  2021-05-11       Impact factor: 4.147

Review 5.  Optimal dietary approaches for prevention of type 2 diabetes: a life-course perspective.

Authors:  A E Buyken; P Mitchell; A Ceriello; J Brand-Miller
Journal:  Diabetologia       Date:  2010-01-05       Impact factor: 10.122

6.  Mitogenic action of insulin: friend, foe or 'frenemy'?

Authors:  B Draznin
Journal:  Diabetologia       Date:  2009-10-23       Impact factor: 10.122

Review 7.  Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents.

Authors:  Antonino Di Pino; Ralph A DeFronzo
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

8.  Cardiac overexpression of catalase rescues cardiac contractile dysfunction induced by insulin resistance: Role of oxidative stress, protein carbonyl formation and insulin sensitivity.

Authors:  F Dong; C X Fang; X Yang; X Zhang; F L Lopez; J Ren
Journal:  Diabetologia       Date:  2006-04-04       Impact factor: 10.122

Review 9.  Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival.

Authors:  Cecilia C Low Wang; Jane E B Reusch
Journal:  Am J Cardiol       Date:  2012-11-06       Impact factor: 2.778

10.  Spironolactone prevents dietary-induced metabolic syndrome by inhibiting PI3-K/Akt and p38MAPK signaling pathways.

Authors:  H D Long; Y E Lin; M J Liu; L Y Liang; Z H Zeng
Journal:  J Endocrinol Invest       Date:  2013-04-23       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.